Shanghai Institute of Materia Medica

Shanghai Institute of Materia Medica
Name	Shanghai Institute of Materia Medica
Established	1932
Type	Research institute
Location	Shanghai, China
Parent	Chinese Academy of Sciences

Contents

Shanghai Institute of Materia Medica is a major biomedical research institute based in Shanghai with a focus on pharmaceutical sciences, drug discovery, and translational medicine. The institute interacts with institutions such as Chinese Academy of Sciences, Fudan University, Shanghai Jiao Tong University, Peking University, and Tsinghua University, and it contributes to national initiatives like National Natural Science Foundation of China, 863 Program, and National Key R&D Program of China. The institute's work links to international frameworks exemplified by connections to World Health Organization, European Medicines Agency, U.S. Food and Drug Administration, Bill & Melinda Gates Foundation, and Wellcome Trust.

History

The institute traces roots to early pharmaceutical research centers in Shanghai and expanded through collaborations with entities like Academy of Sciences of the Soviet Union, Ministry of Health of the People's Republic of China, Nationalist Government (Republic of China), People's Liberation Army, and post-1949 reorganizations involving Zhejiang University, Sun Yat-sen University, and Shanghai Medical College. During the reform era the institute engaged with programs such as National High-Tech R&D Program (863 Program), State Council of the People's Republic of China, China Medical Board, and Chinese Academy of Medical Sciences, while establishing partnerships with GlaxoSmithKline, Pfizer, Roche, AstraZeneca, and Novartis. Over decades it has been recognized by awards including State Natural Science Award (China), State Scientific and Technological Progress Award, Chinese Academy of Sciences Outstanding Science and Technology Achievement Award, and honors linked to figures such as Tu Youyou, Chen Zhu, Yuan Longping, Deng Xiaoping, and Jiang Zemin.

The institute is administered within structures of the Chinese Academy of Sciences and coordinates with administrative bodies such as Shanghai Municipal Government, Ministry of Science and Technology of the People's Republic of China, Ministry of Education of the People's Republic of China, Shanghai Science and Technology Commission, and provincial research bureaus connected to Zhejiang Provincial Government and Jiangsu Provincial Government. Leadership roles mirror those in institutions like Institute Pasteur, Max Planck Society, National Institutes of Health (United States), Karolinska Institute, and Scripps Research, and managerial units interface with entities such as China National Intellectual Property Administration, State Intellectual Property Office, China Food and Drug Administration, and Shanghai Drug Administration.

Research spans drug discovery pipelines paralleling work at Genentech, Amgen, Merck & Co., Bayer AG, and Sanofi, and includes medicinal chemistry aligned with programs at Massachusetts Institute of Technology, Harvard University, California Institute of Technology, University of Cambridge, and University of Oxford. Major domains include natural products research with reference to Traditional Chinese Medicine, collaborations echoing Peking Union Medical College Hospital, China Academy of Chinese Medical Sciences, and translational oncology efforts comparable to Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, and MD Anderson Cancer Center. Other programs address pharmacology and toxicology related to European Pharmacopoeia, United States Pharmacopeia, ICH, and chemical biology interfaces seen at Broad Institute, Cold Spring Harbor Laboratory, and Howard Hughes Medical Institute.

Facilities include analytical platforms similar to those at Shanghai Synchrotron Radiation Facility, National Center for Protein Sciences (Beijing), and National Center for Drug Screening, with laboratories equipped like European Molecular Biology Laboratory, Riken, and Lawrence Berkeley National Laboratory. Core instruments and units mirror setups in National Laboratory of Biomacromolecules, Protein Data Bank, Human Genome Project, Cryo-EM facilities, and high-throughput screening centers comparable to Genomics Institute of the Novartis Research Foundation, Illumina, and Thermo Fisher Scientific. The institute hosts animal facilities following standards from Association for Assessment and Accreditation of Laboratory Animal Care International, Office of Laboratory Animal Welfare, and biosafety frameworks akin to Biosafety Level 3 infrastructures.

The institute's achievements are comparable to landmark efforts linked to Tu Youyou's antimalarial discovery, breakthroughs in small molecule therapeutics akin to Imatinib, and contributions resonant with awards such as State Natural Science Award (China), State Technological Invention Award (China), and recognition from Chinese Academy of Sciences. Its scientists have published alongside authors from Nature, Science, Cell (journal), The Lancet, and New England Journal of Medicine and participated in international projects with Human Genome Project, International HapMap Project, and 1000 Genomes Project collaborators. The institute has advanced compounds into clinical trials under oversight from China Food and Drug Administration, U.S. Food and Drug Administration, and European Medicines Agency.

Training programs include graduate education in collaboration with University of Chinese Academy of Sciences, joint doctoral programs like those with Fudan University, postdoctoral fellowships modeled on Marie Skłodowska-Curie Actions, and summer schools reminiscent of initiatives at Cold Spring Harbor Laboratory and EMBO. The institute mentors students who proceed to positions at institutions such as Peking University, Tsinghua University, Shanghai Jiao Tong University, Harvard Medical School, and Stanford University School of Medicine and participates in talent programs like National Ten Thousand Talents Program, Thousand Talents Plan, and Youth Thousand Talents Program.

Category:Research institutes in China Category:Pharmaceutical research institutes Category:Chinese Academy of Sciences institutions